Timothy Harrison

3.4k total citations
52 papers, 1.7k citations indexed

About

Timothy Harrison is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Timothy Harrison has authored 52 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 12 papers in Organic Chemistry. Recurrent topics in Timothy Harrison's work include Neuropeptides and Animal Physiology (15 papers), Receptor Mechanisms and Signaling (12 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). Timothy Harrison is often cited by papers focused on Neuropeptides and Animal Physiology (15 papers), Receptor Mechanisms and Signaling (12 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). Timothy Harrison collaborates with scholars based in United Kingdom, United States and Spain. Timothy Harrison's co-authors include Christopher J. Swain, N.M.J. Rupniak, Brian J. Williams, Alan Wheeldon, Andrew P. Owens, Stephen P. Hunt, Dirk Beher, C. De Felipe, Bryan Oates and Richard G. Ball and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Neuroscience and Cancer.

In The Last Decade

Timothy Harrison

52 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy Harrison United Kingdom 25 1.1k 611 406 217 199 52 1.7k
Francesco G. Salituro United States 27 923 0.9× 462 0.8× 357 0.9× 186 0.9× 64 0.3× 45 1.8k
Gary G. Chicchi United States 29 1.5k 1.4× 784 1.3× 473 1.2× 117 0.5× 219 1.1× 65 2.5k
Adil J. Nazarali Canada 23 1.3k 1.3× 361 0.6× 354 0.9× 125 0.6× 172 0.9× 77 2.4k
Grazia Lombardi Italy 29 1.1k 1.0× 792 1.3× 212 0.5× 113 0.5× 216 1.1× 66 2.3k
Shil Patel United States 29 1.3k 1.2× 1.1k 1.8× 471 1.2× 80 0.4× 115 0.6× 59 2.4k
Frédéric Bihel France 27 817 0.8× 393 0.6× 643 1.6× 112 0.5× 426 2.1× 85 1.9k
John S. Shaw United Kingdom 21 1.1k 1.0× 1.3k 2.1× 263 0.6× 85 0.4× 431 2.2× 34 2.2k
Krystyna M. Wozniak United States 28 1.0k 1.0× 1.2k 1.9× 185 0.5× 502 2.3× 363 1.8× 70 2.5k
Martin Missbach Switzerland 19 765 0.7× 190 0.3× 317 0.8× 275 1.3× 149 0.7× 25 1.6k
Yves Mérand Canada 24 545 0.5× 308 0.5× 143 0.4× 209 1.0× 106 0.5× 49 1.6k

Countries citing papers authored by Timothy Harrison

Since Specialization
Citations

This map shows the geographic impact of Timothy Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Harrison more than expected).

Fields of papers citing papers by Timothy Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Harrison. The network helps show where Timothy Harrison may publish in the future.

Co-authorship network of co-authors of Timothy Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Harrison. A scholar is included among the top collaborators of Timothy Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Harrison. Timothy Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wappett, Mark, Julien Daubriac, Ian Lobb, et al.. (2024). USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF. Clinical and Translational Medicine. 14(4). e1648–e1648. 9 indexed citations
2.
Khawaja, Hajrah, Andrew D. Campbell, Jamie Z. Roberts, et al.. (2020). RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer. Cell Death and Disease. 11(10). 930–930. 14 indexed citations
3.
Higgins, Catherine, Joanna Majkut, Tamas Sessler, et al.. (2020). A revised model of TRAIL ‐R2 DISC assembly explains how FLIP (L) can inhibit or promote apoptosis. EMBO Reports. 21(3). e49254–e49254. 40 indexed citations
4.
Eddie, Sharon L., Stephanie G. Burton, Timothy Harrison, et al.. (2019). Identification and SAR exploration of a novel series of Legumain inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(12). 1546–1548. 4 indexed citations
5.
Gavory, Gérald, C. O'Dowd, Matthew Helm, et al.. (2017). Discovery and characterization of highly potent and selective allosteric USP7 inhibitors. Nature Chemical Biology. 14(2). 118–125. 165 indexed citations
6.
Bradley, Conor A., Joanna Majkut, Catherine Higgins, et al.. (2016). FLIP: A Targetable Mediator of Resistance to Radiation in Non–Small Cell Lung Cancer. Molecular Cancer Therapeutics. 15(10). 2432–2441. 19 indexed citations
7.
Eddie, Sharon L., et al.. (2015). Flat SAR of P3-methylsulphonamide based small molecule legumain inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(2). 413–416. 5 indexed citations
8.
Eddie, Sharon L., Catherine Higgins, Zenobia D’Costa, et al.. (2015). Development of a potent and selective cell penetrant Legumain inhibitor. Bioorganic & Medicinal Chemistry Letters. 25(23). 5642–5645. 15 indexed citations
9.
Valentine, Andrea, Martin O’Rourke, Anita Yakkundi, et al.. (2011). FKBPL and Peptide Derivatives: Novel Biological Agents That Inhibit Angiogenesis by a CD44-Dependent Mechanism. Clinical Cancer Research. 17(5). 1044–1056. 44 indexed citations
10.
Sparey, Tim, Earl E. Clarke, Timothy Harrison, et al.. (2007). Sulfonamide derivatives of bridgehead substituted bicyclo[4.2.1]nonanes as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 375–379. 7 indexed citations
11.
Lewis, Stephen J., Adrian L. Smith, Joseph G. Neduvelil, et al.. (2004). A novel series of potent γ-secretase inhibitors based on a benzobicyclo[4.2.1]nonane core. Bioorganic & Medicinal Chemistry Letters. 15(2). 373–378. 35 indexed citations
12.
Nadin, Alan, Andrew P. Owens, José L. Castro, Timothy Harrison, & Mark S. Shearman. (2003). Synthesis and γ-secretase activity of APP substrate-based hydroxyethylene dipeptide isosteres. Bioorganic & Medicinal Chemistry Letters. 13(1). 37–41. 18 indexed citations
13.
Owens, Andrew P., Alan Nadin, Adam C. Talbot, et al.. (2003). High affinity, bioavailable 3-Amino-1,4-benzodiazepine-Based γ-Secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(22). 4143–4145. 25 indexed citations
14.
Maubach, Karen, Karine Martin, Gary G. Chicchi, et al.. (2002). Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus. Neuroscience. 109(3). 609–617. 60 indexed citations
15.
Seward, Eileen M., Emma Carlson, Timothy Harrison, et al.. (2002). Spirocyclic NK1 antagonists I: [4.5] and [5.5]-Spiroketals. Bioorganic & Medicinal Chemistry Letters. 12(18). 2515–2518. 22 indexed citations
16.
Maubach, Karen, Karine Martin, David W. Smith, et al.. (2001). Substance P stimulates inhibitory synaptic transmission in the guinea pig basolateral amygdala in vitro. Neuropharmacology. 40(6). 806–817. 32 indexed citations
17.
Rupniak, N.M.J., Emma Carlson, J.K. Webb, et al.. (2001). Comparison of the phenotype of NK1R−/− mice with pharmacological blockade of the substance P (NK 1 ) receptor in assays for antidepressant and anxiolytic drugs. Behavioural Pharmacology. 12(6). 497–508. 125 indexed citations
18.
Harrison, Timothy, Mads P. G. Korsgaard, Christopher J. Swain, et al.. (1998). High affinity, selective neurokinin 2 and neurokinin 3 receptor antagonists from a common structural template. Bioorganic & Medicinal Chemistry Letters. 8(11). 1343–1348. 21 indexed citations
19.
Owens, Andrew P., Timothy Harrison, Jonathan D. Moseley, et al.. (1998). High affinity phenylglycinol-based NK1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 8(1). 51–56. 6 indexed citations
20.
Seabrook, Guy R., Sara L. Shepheard, David J. Williamson, et al.. (1996). L-733,060, a novel tachykinin NK1 receptor antagonist; effects in [Ca2+]i mobilisation, cardiovascular and dural extravasation assays. European Journal of Pharmacology. 317(1). 129–135. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco G. Salituro Breakdown of academic impact, for papers by Gary G. Chicchi Breakdown of academic impact, for papers by Adil J. Nazarali Breakdown of academic impact, for papers by Grazia Lombardi Breakdown of academic impact, for papers by Shil Patel Breakdown of academic impact, for papers by Frédéric Bihel Breakdown of academic impact, for papers by John S. Shaw Breakdown of academic impact, for papers by Krystyna M. Wozniak Breakdown of academic impact, for papers by Martin Missbach Breakdown of academic impact, for papers by Yves Mérand
Rankless by CCL
2026